Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis

Qin et al. Reproductive Biology and Endocrinology (2023) 21:104 https://doi.org/10.1186/s12958-023-01158-7 CORRECTION Correction: Mifepristone inhibited the expression of B7-H2, B7-H3, B7-H4 and PD-L2 in adenomyosis Xiaoyan Qin1, Wenjing Sun1, Chong Wang2, Mingjiang Li1, Xingbo Zhao3, Changzhong Li1 and Hui Zhang1* Correction: Reprod Biol Endocrinol 19, 114 (2021) https://doi.org/10.1186/s12958-021-00800-6 Following publication of the original article [1], the authors identified an error in Fig.  2. The correct figure is given below. The original article [1] has been updated. Open Access © The Author(s) 2023. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecom- mons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. Reproductive Biology and Endocrinology The original article can be found online at https:// doi. org/ 10. 1186/ s12958- 021- 00800-6. *Correspondence: Hui Zhang [email protected] 1 Department of Obstetrics and Gynaecology, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, People’s Republic of China 2 Department of Surgery, Shandong Rongjun General Hospital, Jinan, Shandong 250013, People’s Republic of China 3 Department of Obstetrics and Gynaecology, Shandong University, Jinan, Shandong 250000, People’s Republic of China Page 2 of 2Qin et al. Reproductive Biology and Endocrinology (2023) 21:104 Reference 1. Qin X, Sun W, Wang C, et al. Mifepristone inhibited the expression of B7–H2, B7–H3, B7–H4 and PD-L2 in adenomyosis. Reprod Biol Endocrinol. 2021;19:114. https:// doi. org/ 10. 1186/ s12958- 021- 00800-6. Fig. 2 Immunoexpression and comparison of B7-H3 in normal, eutopic and ectopic endometrium of adenomyosis treated with and without mifepristone. a Ectopic endometrium of proliferative phase in patient with untreated adenomyosis (n = 35); b Ectopic endometrium of secretory phase in patient with untreated adenomyosis (n = 23); c Eutopic endometrium of proliferative phase in patient with untreated adenomyosis (n = 35); d Eutopic endometrium of secretory phase in patient with untreated adenomyosis (n = 23); e Normal endometrium of proliferative phase in patients without adenomyosis (n = 47); f Normal endometrium of secretory phase in patients without adenomyosis (n = 27); g Ectopic endometrium in patient with mifepristone-treated adenomyosis (n = 11); h and i eutopic endometrium in patient with mifepristone-treated adenomyosis (n = 11); j Immunoscore comparation of B7-H3 between each groups, * P < 0.05, ** P < 0.01. a- i magnification: × 100